Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N G Guseva

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Revmatologiia (Moscow, Russia)|July 1, 1989
[Differential diagnosis of diffuse eosinophilic fasciitis]N G Guseva, Zh D Abdykhalykova, M S Venikova, et al.
Revmatologiia (Moscow, Russia)|January 1, 1986
[Working classification and nomenclature of rheumatic diseases (1985)]E R Agababova, M G Astapenko, L I Benevolenskaia, et al.
Revmatologiia (Moscow, Russia)|July 1, 1983
[Effect of rheopolyglucin on microcirculation function in systemic scleroderma]R M Balabanova, N G Guseva, N P Apenysheva, et al.
Terapevticheskii Arkhiv|January 1, 1986
[Antinuclear antibodies in Sjögren's disease and syndrome]Z Z Kirtava, N G Guseva, V I Vasil'ev, et al.
Revmatologiia (Moscow, Russia)|July 1, 1990
[Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma]A I Speranskiĭ, T A Riazantseva, N G Guseva, et al.
Terapevticheskii Arkhiv|January 1, 1985
[Correction of microcirculatory disorders in rheumatic diseases]N G Guseva, A S Poltyrev, V I Alekseev, et al.
Terapevticheskii Arkhiv|January 1, 1985
[Clinico-morphological characteristics and working classification of kidney diseases in patients with systemic scleroderma]N G Guseva, N V Anikina, I A Borisov, et al.
Terapevticheskii Arkhiv|January 1, 1988
[Clinical significance of anti-Ro and anti-La antigen antibodies in Sjögren's disease and syndrome]Z Z Kirtava, N G Guseva, M V Simonova, et al.
Vestnik Rentgenologii I Radiologii|September 1, 1972
[X-ray characteristics of esophageal involvement in systemic scleroderma]L I Ganchenko, V M Arablinskiĭ, N G Guseva, et al.
Terapevticheskii Arkhiv|January 1, 1985
[Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma]Iu V Murav'ev, A P Aliab'eva, Ia A Sigidin, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Revmatologiia (Moscow, Russia)|July 1, 1989
[Differential diagnosis of diffuse eosinophilic fasciitis]N G Guseva, Zh D Abdykhalykova, M S Venikova, et al.
Revmatologiia (Moscow, Russia)|January 1, 1986
[Working classification and nomenclature of rheumatic diseases (1985)]E R Agababova, M G Astapenko, L I Benevolenskaia, et al.
Revmatologiia (Moscow, Russia)|July 1, 1983
[Effect of rheopolyglucin on microcirculation function in systemic scleroderma]R M Balabanova, N G Guseva, N P Apenysheva, et al.
Terapevticheskii Arkhiv|January 1, 1986
[Antinuclear antibodies in Sjögren's disease and syndrome]Z Z Kirtava, N G Guseva, V I Vasil'ev, et al.
Revmatologiia (Moscow, Russia)|July 1, 1990
[Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma]A I Speranskiĭ, T A Riazantseva, N G Guseva, et al.
Terapevticheskii Arkhiv|January 1, 1985
[Correction of microcirculatory disorders in rheumatic diseases]N G Guseva, A S Poltyrev, V I Alekseev, et al.
Terapevticheskii Arkhiv|January 1, 1985
[Clinico-morphological characteristics and working classification of kidney diseases in patients with systemic scleroderma]N G Guseva, N V Anikina, I A Borisov, et al.
Terapevticheskii Arkhiv|January 1, 1988
[Clinical significance of anti-Ro and anti-La antigen antibodies in Sjögren's disease and syndrome]Z Z Kirtava, N G Guseva, M V Simonova, et al.
Vestnik Rentgenologii I Radiologii|September 1, 1972
[X-ray characteristics of esophageal involvement in systemic scleroderma]L I Ganchenko, V M Arablinskiĭ, N G Guseva, et al.
Terapevticheskii Arkhiv|January 1, 1985
[Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma]Iu V Murav'ev, A P Aliab'eva, Ia A Sigidin, et al.
Pageof 12